R
A
Last name: ROSSIN
First name: Aurelie
Email: Aurelie.ROSSIN@univ-cotedazur.fr
Institution: UCA
Links
International audience
Hepatocellular carcinoma (HCC) represents 80% of the primary hepatic neoplasms. It is the sixth most frequent neoplasm, the fourth cause of cancer-related death, and 7% of registered malignancies. Sorafenib is the first line molecular targeted therapy for patients in advanced stage of HCC. The present study shows that Sorafenib exerts free...